Natural Cholesterol Support.

Plant sterols are structurally close enough to cholesterol to compete with it for space in intestinal mixed micelles, so less cholesterol is presented for uptake at that meal. A published human study paired a plant sterol supplement with a specific Lactiplantibacillus plantarum strain and reported on blood lipid measures, which are markers rather than clinical outcomes. Sterols are themselves poorly absorbed, which is why the competition happens in the lumen rather than in the blood.

Certain Lactiplantibacillus plantarum strains carry bile salt hydrolase, which deconjugates bile acids and reduces their reabsorption in the ileum. The liver then draws on cholesterol to make replacement bile acids. The published combination with plant sterols reported on lipid markers, and the effect is strain specific rather than a property of probiotics generally.

Psyllium forms a viscous gel that traps bile acids and carries them out in stool instead of letting them be reabsorbed at the terminal ileum. The liver replaces the lost bile acids using cholesterol as the starting material. Viscosity is what does the work, so a non-gelling fibre does not substitute.

Oat beta-glucan raises the viscosity of intestinal contents, which slows micelle diffusion to the brush border and increases faecal bile acid loss. This is the most extensively characterised viscous-fibre route for supporting blood lipid levels already in the normal range. Milling and processing that cut the molecular weight also cut the viscosity, and with it the effect.

Guar galactomannan is highly viscous at low concentration and acts on bile acid recirculation the same way other gel-forming fibres do. Partially hydrolysed guar gum is deliberately made low-viscosity for tolerability, which removes that particular mechanism. The two guar grades should not be read as interchangeable here.

High-methoxyl citrus and apple pectins gel in the small intestine and bind bile acids. Degree of esterification and molecular weight both change how much viscosity a given dose produces. As with other viscous fibres, the property that matters is the gel, not the fibre label.

Konjac glucomannan takes up many times its weight in water and is among the more viscous soluble fibres available. That viscosity slows lipid micelle transport to the absorptive surface. It also carries a choking caution when taken dry, which belongs on any label using it.

Monascus-fermented rice contains monacolin K, which is the same molecule as lovastatin and inhibits HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis. Monacolin content varies widely between preparations because it depends on the fermentation. Stacking it with any other HMG-CoA reductase inhibitor is additive on the same enzyme, and that is exactly why it is not a casual combination.

The mevalonate pathway that HMG-CoA reductase controls supplies not only cholesterol but the isoprenoid tail of coenzyme Q10. Anything that inhibits that enzyme therefore reduces flux to both products. This is why coenzyme Q10 is conventionally paired with monacolin-containing preparations, and the pairing is mechanistic rather than a demonstrated outcome.

Berberine raises hepatic LDL receptor expression by stabilising its messenger RNA, a route entirely separate from inhibiting synthesis. Because the mechanisms differ, berberine and a synthesis-side ingredient are not redundant. Berberine also inhibits CYP3A4 and P-glycoprotein, which matters for anything else being taken.

Garlic organosulfur compounds have been studied against blood lipid markers with modest and inconsistent results across preparations. Aged garlic extract differs chemically from raw garlic and from allicin-standardised powders, so trial findings do not carry across forms. The measurements are markers, not clinical events.

Long-chain omega-3 fatty acids act mainly on hepatic triglyceride assembly and secretion, a different lipid fraction from the one sterols and fibres act on. A large prospective cohort reported an association between fish oil supplement use and incidence of elevated liver fat, and an association in a cohort is not a causal effect. The two ingredients address different parts of a lipid panel rather than compounding on one.

Immediate-release nicotinic acid at gram-scale doses acts on hepatic lipoprotein handling and produces the well known flushing response through prostaglandin D2 release. Nicotinamide and inositol hexanicotinate do not share that pharmacology, so the form on the label decides what is happening. Gram-scale nicotinic acid is a pharmacological dose and is not a casual addition to a blend.

Gamma and delta tocotrienols promote degradation of HMG-CoA reductase protein, a post-translational route distinct from competitive inhibition of the enzyme. Alpha-tocopherol does not do this and can interfere with tocotrienol uptake when both are present. A mixed tocopherol product is therefore not a source of this mechanism.

Fermentation of inulin yields propionate, which reaches the liver through the portal vein and has been described as a modulator of hepatic lipid synthesis. The evidence for that route is largely mechanistic and animal-based. Inulin is not viscous, so it does not act through the bile acid trapping route that psyllium and beta-glucan use.

Resistant starch feeds butyrate and propionate production in the colon, and propionate reaching the liver is the proposed link to hepatic lipid handling. The evidence is mechanistic rather than outcome-based in people. Fermentation load also determines tolerability at higher doses.

Artichoke leaf is used for its cynarin and luteolin content and has been studied against lipid markers in small trials with mixed results. It is also a choleretic, increasing bile flow, which is the mechanistic argument usually made. The evidence base is small and the preparations vary.

A systematic review grouped anthocyanins, curcumin and resveratrol for their reported effects on metabolic markers including blood lipids. Curcumin is poorly absorbed without an enhancer, so the preparation determines whether anything reaches circulation. These are marker changes across heterogeneous studies, not clinical outcomes.

Bile salt hydrolase activity varies by strain, and it is the enzymatic basis for the lipid-related interest in certain lactobacilli. A meta-analysis of probiotic supplementation in adults with excess body weight reported on weight measures, which is a related but separate endpoint from blood lipids. Strain identity does the work, and a generic probiotic label does not carry it.